New York Life Investment Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
N
New York Life Investment Management's ELV Position: Q2 2026 in Review
New York Life Investment Management reduced its Elevance Health (ELV) stake by 1.4% in Q2 2026, selling an estimated $175K and leaving 32,336 shares worth $12.5M. The position accounts for 0.09% of the portfolio, ranked #182.
New York Life Investment Management first reported a position in ELV in Q1 2014 and has held it in 20 quarters since. The position peaked at $22.6M in Q4 2022. 1,176 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- New York Life Investment Management held 32,336 shares of Elevance Health worth $12.5M as of Q2 2026.
- New York Life Investment Management sold 472 Elevance Health shares in Q2 2026, an estimated $175K.
- Elevance Health made up 0.09% of New York Life Investment Management's portfolio in Q2 2026, its #182 holding.
- New York Life Investment Management first reported a position in Elevance Health in Q1 2014 and has held it in 20 quarters since.
- New York Life Investment Management's Elevance Health position peaked at $22.6M in Q4 2022.
- 1,176 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.